- Leveraging MNC CSR for Primary Setup and Drug Listing
We will initiate our operations by partnering with multinational corporations (MNCs) that allocate budgets for Corporate Social Responsibility (CSR) initiatives. These partnerships will provide the necessary seed funding and technical resources to establish our initial infrastructure, including secure storage, logistics, and regulatory compliance systems. Additionally, by collaborating with reputable MNCs, we can build credibility and gain early traction in the market, allowing us to list a comprehensive portfolio of essential drugs sourced from open innovation channels. This initial setup phase, supported by CSR funds, is crucial for laying a robust foundation for our open source pharmacy.
- Optimizing Margins on High-Selling Products
To ensure the financial sustainability of Zeropharma, we plan to incorporate a strategic margin on our higher-selling products. These products, while in high demand, will provide a revenue stream that covers fixed operating costs and ongoing maintenance expenses. By accepting a modest margin on these items, we can subsidize the cost of essential drugs, ensuring that our core mission of affordability is maintained. This dual-pricing model allows us to balance sustainability with social impact—using profits from popular items to support the broader availability of life-saving medications.
- Supplying Drugs to the Public at Maximum Lower Rates
The core objective of Zeropharma is to make essential medications accessible to everyone at the lowest possible cost. Leveraging the efficiencies gained from our open source model, along with the subsidization from CSR-backed infrastructure and optimized margins on high-demand products, we will supply drugs at significantly reduced prices. By ensuring that the majority of our inventory is priced at near-zero margins, we make a tangible impact on affordability, particularly in underserved communities. This approach not only fulfills our social mission but also positions Zeropharma as a leader in providing cost-effective, high-quality healthcare solutions.